{"id":"W4414061569","doi":"10.70962/jhi.20250131","title":"Treatment of severe refractory immune neutropenia with ruxolitinib: Two cases","year":2025,"lang":"en","type":"article","venue":"Journal of Human Immunity","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"Recordati Rare Diseases; Nova Scotia Health Research Foundation; VGH and UBC Hospital Foundation; Pfizer","keywords":"Neutropenia; Refractory (planetary science); Immune system; Ruxolitinib; Lymphocyte; Immunopathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006896343,0.0001392885,0.0002857788,0.00007106399,0.0001224395,0.00001373781,0.00015659,0.00005326052,0.00002672981],"category_scores_gemma":[0.00001542904,0.00009674658,0.0001509741,0.00006231971,0.00008699349,0.000007169222,0.00004130721,0.00008641769,8.395588e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003105797,"about_ca_system_score_gemma":0.0001499281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003791615,"about_ca_topic_score_gemma":0.0001278496,"domain_scores_codex":[0.9992747,0.00009167744,0.0003306464,0.00008882059,0.00008722309,0.0001268952],"domain_scores_gemma":[0.9991252,0.00001980282,0.0003176895,0.0003189694,0.0001782337,0.00004007094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00438312,0.009531057,0.1162359,0.0001220505,0.004718086,0.000422108,0.0006012164,0.00009848879,0.839462,0.000672493,0.001027276,0.02272622],"study_design_scores_gemma":[0.02640149,0.02874429,0.2026473,0.0002841922,0.001052339,0.001117325,0.0017263,0.000001162718,0.7156656,0.000369281,0.02151104,0.0004796843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992417,0.004244123,0.00000602989,0.00004276471,0.00005861871,0.00009121151,0.00001214539,0.000002265168,0.003125775],"genre_scores_gemma":[0.9983214,0.0004308961,0.0001453942,0.00002555465,0.00004130834,0.000003006948,0.00002721543,0.00001061474,0.0009945662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1237964,"threshold_uncertainty_score":0.3945211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01295452105865331,"score_gpt":0.292225286786957,"score_spread":0.2792707657283037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}